Albany, NY -- (SBWIRE) -- 12/14/2016 -- Stem Cells Market: Overview

The rising funding from numerous governments and private organizations globally and the rising inclination toward stem cell research are amongst the prime factors boosting the growth of the global stem cells market. The emergence of numerous stem cell therapies also represent huge development opportunities for the key players in the stem cells market. In addition, the increasing demand for regenerative treatment options globally will positively impact the growth of the overall market.

According to TMR, the worldwide market for stem cells, which reached a value of US$62.2 bn in 2015, is likely to expand at an exponential CAGR of 24.20% between 2012 and 2018 and present a whopping opportunity worth US$119.5 bn by the end of the forecast period. Currently, adult stem cells report a higher demand than other stem cells and will continue to do so over the forecast period. Analysts predict the revenue generated from adult stem cells to reach US$103.8 bn by 2018.

Download Exclusive Global Strategic Business Sample Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

The report makes use of various analysis tools such as SWOT analysis and Porter's five forces analysis in order to present a comprehensive understanding of all the attributes related to the market. A thorough review of the market forces impeding and propelling the growth of the stem cells market also forms an integral part of this study. Furthermore, a vividly defined growth map of the market in terms of technological evolution is presented through this study.

This report presents a comprehensive overview of the global stem cells market as well as its related technologies. It also deploys an in-depth understanding of the strategies adopted by the players specializing within this field in order to meet the growing challenges of a fast-growing and competitive market. The strengths and weaknesses of these players have also been presented in this study.

BrainStorm Cell Therapeutics' NurOwn Could be a Cure for ALS

Some of the important players engaged in the global stem cells market are Cellartis AB, Stemcelltechnologies Inc., Biotime Inc., Cellular Engineering Technologies, Cytori Therapeutics Inc., Bioheart, Celgene Corporation Inc., Osiris Therapeutics, California Stem Cells Inc., Angel Biotechnology, Brainstorm Cell Therapeutics, and Advanced Cell Technology Inc. Several players in the market are trying to solve chronic conditions and diseases with stem cell therapy. For instance, Brainstorm Cell Therapeutics announced that the Data and Safety Monitoring Board (DSMB) conducted the second round of its pre-planned safety review for the double-blind, randomized, placebo-controlled phase 2 clinical trial of NurOwn® for usage in the treatment of amyotrophic lateral sclerosis (ALS).

DSMB stated that Brainstorm could continue its study, as no safety concerns were found in the trial. Data collected for 47 out of 48 patients showed no adverse issues, lab abnormalities, or protocol deviations related to the trial. BrainStorm Cell Therapeutics' NurOwn uses a technique developed by Profs. Eldad Melamed and Daniel Offen, Tel Aviv University. It relates to growing and improving stem cells taken from the patients' own bone marrow. As these cells secrete high levels of nerve-growth factors, they protect motor neurons present in the body, thereby promoting motor neuron growth and restoring nerve-muscle interaction. Such efforts are expected to change the life expectancy of ALS patients and the whole disease management scenario for ALS in the near future.

Currently, North America dominates the global stem cells market. Europe holds the second position with a market share of over 25% in the overall stem cell market. Though analysts predict that this market will reach newer heights in the coming years, the strict regulatory framework against the unethical harvesting of stem cells and high prices of stem cell treatments will limit the growth of this market.

Browse Full Research Report on Global Stem Cells Market:
http://www.transparencymarketresearch.com/stem-cells-market.html

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/